Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Graham Meta-Analysis Ultimately Positive For Celebrex, Bextra

Mar 07 2005

• By The Pink Sheet

Related Content

Bextra, Vioxx Require Stronger Warnings, Additional Study, Cmte. Finds

Feb 28 2005

Celebrex Should Stay On Market, FDA Panel Says, But Splits On Vioxx, Bextra

Feb 21 2005

Merck May Need New Arcoxia Trial Design Prior To FDA Approval

Mar 07 2005

Merck’s “VIGORous” Defense Of Vioxx; Novartis, Wyeth Studies Might Help

Oct 18 2004

COX-2 Retrospective Study Prompts Review By FDA, Kaiser On Merck’s Vioxx

Aug 30 2004

Aleve Warning Gives Pfizer Some Relief, But Is New Headache For FDA

Jan 03 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window